Ambrosia Systems said today that it launched its LinkBlueCon application on the Fitbit and Abbott (NYSE:ABT) FreeStyle Libre smartwatch platforms for glucose monitoring.
San Fransisco-based Ambrosia’s LinkBlueCon app is designed to monitor glucose levels and receive notifications when glucose readings are outside the target range, all without the need to go to a clinic.
Ambrosia said it will make it easier to see health and activity data, such as sleep, heart rate and cardio fitness, and how they can affect glucose levels, on its platform.
Get the full story at our sister site, Drug Delivery Business News.